Proceedings of the 2023 Cannabis Clinical Outcomes Research Conference.

Amie J Goodin, Phuong T Tran, Sam McKee, Ruba Sajdeya, Jeevan Jyot, Robert L Cook, Yan Wang, Almut G Winterstein
Author Information
  1. Amie J Goodin: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.
  2. Phuong T Tran: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.
  3. Sam McKee: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.
  4. Ruba Sajdeya: Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, FL, USA.
  5. Jeevan Jyot: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.
  6. Robert L Cook: Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, FL, USA.
  7. Yan Wang: Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, FL, USA.
  8. Almut G Winterstein: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.

Abstract

The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its third annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2023. CCORC was held as a hybrid conference, with a scientific program consisting of in-person sessions, with some sessions livestreamed to virtual attendees. CCORC facilitated and promoted up-to-date research on the clinical effects of medical cannabis, fostering collaboration and active involvement among scientists, policymakers, industry professionals, clinicians, and other stakeholders. Three themes emerged from conference sessions and speaker presentations: (1) disentangling conflicting evidence for the effects of medical cannabis on public health, (2) seeking solutions to address barriers faced when conducting clinical cannabis research - especially with medical cannabis use in special populations such as those who are pregnant, and (3) unpacking the data behind cannabis use and mental health outcomes. The fourth annual CCORC is planned for the summer of 2024 in Florida, USA.

Keywords

References

  1. JAMA Netw Open. 2022 Dec 1;5(12):e2246912 [PMID: 36515947]
  2. JAMA Netw Open. 2019 Jul 3;2(7):e196471 [PMID: 31322686]
  3. Am J Obstet Gynecol MFM. 2020 Aug;2(3):100137 [PMID: 33089133]
  4. Psychopharmacology (Berl). 2019 Nov;236(11):3341-3352 [PMID: 31201479]
  5. Eur Neuropsychopharmacol. 2020 Jul;36:206-216 [PMID: 32273144]
  6. Drug Alcohol Depend. 2023 Feb 1;243:109760 [PMID: 36638745]
  7. Front Psychiatry. 2023 Mar 07;14:1083334 [PMID: 36960460]
  8. Med Cannabis Cannabinoids. 2022 Oct 17;5(1):138-141 [PMID: 36467782]
  9. Prev Med. 2017 Nov;104:46-49 [PMID: 28528172]

Word Cloud

Created with Highcharts 10.0.0cannabisClinicalOutcomesResearchCannabisConferenceCCORChealthMarijuanasessionsclinicalmedicalMedicalcollaborationFloridaUSAannual2023conferenceresearcheffectsuseoutcomesConsortiummulti-universityestablishedstatehostedthirdMayheldhybridscientificprogramconsistingin-personlivestreamedvirtualattendeesfacilitatedpromotedup-to-datefosteringactiveinvolvementamongscientistspolicymakersindustryprofessionalscliniciansstakeholdersThreethemesemergedspeakerpresentations:1disentanglingconflictingevidencepublic2seekingsolutionsaddressbarriersfacedconducting-especiallyspecialpopulationspregnant3unpackingdatabehindmentalfourthplannedsummer2024ProceedingsCannabidiolCannabinoidsproceedingsefficacymarijuanaMentalPublic

Similar Articles

Cited By